Search results for: Market Access

OHE submission to the UK Parliamentary Inquiry on an Ageing Society

20 May 2025

…The following is an extract from OHE’s written submission to parliament focused on raising population health in older age and increasing access to fertility treatments as two possible avenues to…

New OHE Report: Time Trends in NICE HTA Decisions

25 January 2012

…in access to innovative care and ensure more rapid access to medicines identified as being of value to the NHS. Since NICE’s debut in April 1999, several analyses have examined…

OHE Lunchtime Seminar with Andrea Manca: Economic Evaluation for Decision-making and the Value of Access to Individual Patient Data

16 January 2017

…access to individual patient data. Professor Andrea Manca from the University of York will lead an OHE Lunchtime Seminar on 13th February 2017 on the topic of economic evaluation for…

Latest estimates show that 20 people a day die in unrelieved pain across the UK at the end of their lives

26 November 2024

…by socioeconomic disparities and inequalities in access to healthcare. It’s therefore crucial that population access to palliative care, investment in high-quality end-of-life care and improving pain management is fully considered…

Assessing Value, Budget Impact and Affordability to Inform Discussions on Access and Reimbursement: Principles and Practice, with Special Reference to High Cost Technologies

1 April 2017

…Affordability to Inform Discussions on Access and Reimbursement: Principles and Practice, with Special… The 2016 meeting of the HTAi Asia Policy Forum meeting was held in Kuala Lumpur, 17th -18th…

Digital Health

…infrastructure. These devices offer timely access to diagnostics, accelerating the time from diagnosis to treatment, potentially saving lives in areas where traditional healthcare access is limited. Personalized digital health devices…

Around The World in HTAs: Türkiye – The bumpy road toward transformation

31 January 2024

…Another way to access the market is the Named Patient Program (NPP), which was formulated as an exceptional way of reaching the market. Accordingly, medicines that the TMMDA has yet…

Spotlight on OHE: Assessing Value and Balancing Needs in Health Care

15 December 2011

…Patient Access Schemes, Flexible Pricing Schemes and risk sharing schemes, all of which are becoming increasingly common approaches to shaping access to new drugs. Value based pricing (VBP), due to…

How Much Should Society Pay for a New Orphan Drug? A Contribution to this Debate is now Available in a New OHE Research Paper

18 July 2018

…(OMPs) in the United Kingdom and other European Countries. OHE Consulting Report. OHE Consulting Ltd. Available at: https://www.ohe.org/publications/comparing-access-orphan-medicinal-products-omps-united-kingdom-and-other-european [last accessed: 16 July, 2018] Towse, A. and Garau, M. (2018). Appraising…